Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization

Fetal Diagnosis and Therapy

Volumn 18, Issue 6, 2003, Pages 467-471

  Poissonnier, Marie Helene ^a   Picone, Olivier ^a   Brossard, Yves ^a   Lepercq, Jacques ^a,b  

^a Université Paris V ^*  (France)

^b Hôp Cochin S Vincent de Paul   (France)

Author keywords

Alloimmunization, maternal; Cordocentesis; Intrauterine fetal transfusion; Second trimester

Indexed keywords

HEMOGLOBIN; MATERNAL ANTIBODY; MATERNAL D ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANEMIA; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; FETUS; GESTATIONAL AGE; HUMAN; HYDROPS; INTRAUTERINE BLOOD TRANSFUSION; OUTCOMES RESEARCH; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; RED CELL FETOMATERNAL ALLOIMMUNIZATION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGE FACTORS; BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; PREGNANCY; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; UMBILICAL VEINS;

EID: 0142227876     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073145     Document Type: Article

References (21)

1. Poissonnier MH, Brossard Y, Soulie JC, May-nier M, Larsen M, de Lachaux V, et al: Incom-patibilité foetomaternelle érythrocytaire. Encycl Méd Chir Gynécologie/Obstétrique. Paris, Elsevier, 1998, vol 5, 020-A20.
2. Chavez GF, Mulinare J, Edmonds LD: Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991;265: 3270-3274.
3. Bowman J: The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997;21:39-44.
4. McKenna DS, Nagaraja HN, O'Shaughnessy R: Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999;93:667-673.
5. Grant SR, Kilby MD, Meer L, Weaver JB, Gabra GS, Whittle MJ: The outcome of pregnancy in Kell alloimmunisation. Br J Obstet Gynaecol 2000;107:481-485.
6. Schumacher B, Moise KJ Jr: Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-150.
7. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, et al: Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol 1991;165:1302-1307.
8. Radunovic N, Lockwood CJ, Alvarez M, Ple-cas D, Chitkara U, Berkowitz RL: The severely anemic and hydropic isoimmune fetus: Changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992;79: 390-393.
9. Ulm B, Ulm MR, Deutinger J, Bernaschek G: Twenty-four cordocenteses in one woman. Fetal Diagn Ther 1999;14:283-285.
10. Berkowitz RL, Chitkara U, Wilkins IA, Lynch L, Plosker H, Bernstein HH: Intravascular monitoring and management of erythroblasto-sis fetalis. Am J Obstet Gynecol 1988;158:783-795.
11. Poissonnier MH, Brossard Y, Demedeiros N, Vassileva J, Parnet F, Larsen M, et al: Two hundred intrauterine exchange transfusions in severe blood incompatibilities. Am J Obstet Gynecol 1989;161:709-713.
12. Westgren M, Selbing A, Stangenberg M: Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation. Br Med J 1988; 296:885-886.
13. Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibashan RS, Campbell S: Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988; i:1073-1075.
14. Ryan G, Morrow RJ: Fetal blood transfusion. Clin Perinatol 1994;21:573-589.
15. Divakaran TG, Waugh J, Clark TJ, Khan KS, Whittle MJ, Kilby MD: Noninvasive techniques to detect fetal anemia due to red blood cell alloimmunization: A systematic review. Obstet Gynecol 2001;98:509-517.
16. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al: Noninva-sive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloim-munization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
17. Queenan JT, Tomai TP, Ural SH, King JC: Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: A proposal for clinical management. Am J Obstet Gynecol 1993;168:1370-1376.
18. Scott F, Chan FY: Assessment of the clinical usefulness of the 'Queenan' chart versus the 'Liley' chart in predicting severity of rhesus iso-immunization. Prenat Diagn 1998;18:1143-1148.
19. Weiner CP, Okamuar K: Diagnostic fetal blood sampling-technique related losses. Fetal Diagn Ther 1996;11:169-175.
20. Ghidini A, Sepulveda W, Lockwood CJ, Rom-ero R: Complications of fetal blood sampling. Am J Obstet Gynecol 1993;168:1339-1344.
21. Harman CR, Bowman JM, Manning FA, Men-ticoglou SM: Intrauterine transfusion - Intra-peritoneal versus intravascular approach: A case-control comparison. Am J Obstet Gynecol 1990;162:1053-1059.